Abstract
Introduction
To overcome the limitations regarding transrectal ultrasound (TRUS)-guided biopsies in prostate cancer (PCa) detection, there is a focus on new imaging technologies. The Navigo™ system (UC-care, Israel) uses regular TRUS images and electrospatial monitoring to generate a 3D model of the prostate. The aim of this study was to compare cancer detection rates between the Navigo™ system and conventional TRUS, in patients without a history of PCa.
Methods
We performed a retrospective study by collecting data from all patients who underwent 12-core prostate biopsies from lateral peripheral zones between September 2013 and February 2015 at the Jeroen Bosch Hospital in ‘s-Hertogenbosch (Netherlands).
Results
A total of 325 patients met our inclusion criteria. 77.8 % of biopsy sessions were performed using the Navigo™ system. There was no statistically significant difference in PCa detection (39.9 vs 46.2 % with Navigo™ system and TRUS, respectively). Using the Navigo™ system for taking prostate biopsies proved not to be associated with the presence of PCa at biopsy, likewise for clinically significant PCa and for both subgroups.
Limitations
The limitations of the study include its retrospective design, the limited number of patients in the conventional TRUS group, the statistically significant different number of biopsy sessions and the ones performed by an advanced physician in both groups.
Conclusion
In our study, there is no added value of 3D TRUS using Navigo™ system compared to conventional 2D TRUS regarding PCa detection in biopsy-naive men and men with prior negative biopsy.
Similar content being viewed by others
References
Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 65(1):124–137. doi:10.1016/j.eururo.2013.09.046
Roehl KA, Antenor JA, Catalona WJ (2002) Serial biopsy results in prostate cancer screening study. J Urol 167(6):2435–2439. doi:10.1016/S0022-5347(05)64999-3
Guichard G, Larre S, Gallina A, Lazar A, Faucon H, Chemama S et al (2007) Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 52(2):430–435. doi:10.1016/j.eururo.2007.02.062
Ploussard G, Salomon L, Xylinas E, Allory Y, Vordos D, Hoznek A et al (2010) Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance—Does the risk of misclassification vary according to biopsy criteria? J Urol 183(2):539–544. doi:10.1016/j.juro.2009.10.009
Bul M, Zhu X, Rannikko A, Staerman F, Valdagni R, Pickles T et al (2012) Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol 62(2):195–200. doi:10.1016/j.eururo.2012.02.002
Bax J, Cool D, Gardi L, Knight K, Smith D, Montreuil J et al (2008) Mechanically assisted 3D ultrasound guided prostate biopsy system. Med Phys 35(12):5397–5410. doi:10.1118/1.3002415
Cool D, Downey D, Izawa J, Chin J, Fenster A (2006) 3D prostate model formation from non-parallel 2D ultrasound biopsy images. Med Image Anal 10(6):875–887. doi:10.1016/j.media.2006.09.001
Cool D, Sherebrin S, Izawa J, Chin J, Fenster A (2008) Design and evaluation of a 3D transrectal ultrasound prostate biopsy system. Med Phys 35(10):4695–4707. doi:10.1118/1.2977542
Cool DW, Connolly MJ, Sherebrin S, Eagleson R, Izawa JI, Amann J et al (2010) Repeat prostate biopsy accuracy: simulator-based comparison of two- and three-dimensional transrectal US modalities. Radiology 254(2):587–594. doi:10.1148/radiol.2542090674
Sedelaar JP, van Roermund JG, van Leenders GL, Hulsbergen-van de Kaa CA, Wijkstra H, de la Rosette JJ (2001) Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 57(5):914–920. doi:10.1016/S0090-4295(00)01115-8
Peltier A, Aoun F, El-Khoury F, Hawaux E, Limani K, Narahari K et al (2013) 3D versus 2d systematic transrectal ultrasound-guided prostate biopsy: higher cancer detection rate in clinical practice. Prostate Cancer 2013:783243. doi:10.1155/2013/783243
Cohen M (2012) 3D TRUS prostate biopsy recording and guidance—the Navigo system. Eur Urol 11(1):816. doi:10.1016/S1569-9056(12)60813-6
Twisk JWR (2007) Introductie in de toegepaste biostatistiek. Elsevier, Amsterdam
Hori S, Fuge O, Trabucchi K, Donaldson P, McLoughlin J (2013) Can a trained non-physician provider perform transrectal ultrasound-guided prostatic biopsies as effectively as an experienced urologist? BJU Int 111(5):739–744. doi:10.1111/j.1464-410X.2012.11294.x
El Fegoun AB, El Atat R, Choudat L, El Helou E, Hermieu JF, Dominique S et al (2013) The learning curve of transrectal ultrasound-guided prostate biopsies: implications for training programs. Urology 81(1):12–15. doi:10.1016/j.urology.2012.06.084
Gayet M, van der Aa A, Beerlage HP, Schrier BP, Mulders PF, Wijkstra H (2015) The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review. BJU Int. doi:10.1111/bju.13247
van Hove A, Savoie PH, Maurin C, Brunelle S, Gravis G, Salem N et al (2014) Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies. World J Urol 32(4):847–858. doi:10.1007/s00345-014-1332-3
Acknowledgments
The present study was undertaken with a research grant from Astellas Pharma Netherlands B. V. Astellas has not influenced the content of this manuscript.
Authors’ contribution
A van der Aa was involved in data collection and manuscript writing; H. Beerlage, M. Mischi, P. Mulders, B. Schrier and H. Wijkstra was involved in protocol/project development; M. Gayet was involved in data collection and management, data analysis and manuscript writing; and P. Schmitz was involved in data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Gayet, M., van der Aa, A., Schmitz, P. et al. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection. World J Urol 34, 1255–1260 (2016). https://doi.org/10.1007/s00345-016-1775-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-016-1775-9